Roche (ROG) Given a CHF 285 Price Target at Jefferies Group

Jefferies Group set a CHF 285 price objective on Roche (VTX:ROG) in a research report sent to investors on Friday. The firm currently has a buy rating on the healthcare company’s stock.

ROG has been the subject of several other reports. Societe Generale set a CHF 190 price objective on shares of Roche and gave the stock a sell rating in a research report on Monday, January 15th. Goldman Sachs set a CHF 300 price objective on shares of Roche and gave the stock a buy rating in a research report on Tuesday, March 20th. JPMorgan Chase & Co. set a CHF 300 price objective on shares of Roche and gave the stock a buy rating in a research report on Thursday, January 4th. Barclays set a CHF 305 price objective on shares of Roche and gave the stock a buy rating in a research report on Thursday, December 21st. Finally, Nord/LB restated a buy rating on shares of Roche in a research report on Wednesday, December 27th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of CHF 254.80.

How to Become a New Pot Stock Millionaire

Shares of Roche (VTX ROG) opened at CHF 219.60 on Friday. The stock has a market cap of $191,160.00 and a PE ratio of 21.87. Roche has a one year low of CHF 214.30 and a one year high of CHF 273.

TRADEMARK VIOLATION NOTICE: “Roche (ROG) Given a CHF 285 Price Target at Jefferies Group” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://www.tickerreport.com/banking-finance/3303426/roche-rog-given-a-chf-285-price-target-at-jefferies-group.html.

Roche Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche (VTX:ROG)

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Virtus Investment Partners  Scheduled to Post Quarterly Earnings on Thursday
Virtus Investment Partners Scheduled to Post Quarterly Earnings on Thursday
NXP Semiconductors  Scheduled to Post Quarterly Earnings on Wednesday
NXP Semiconductors Scheduled to Post Quarterly Earnings on Wednesday
CEVA  to Release Earnings on Wednesday
CEVA to Release Earnings on Wednesday
Ottawa Savings Bancorp  Scheduled to Post Earnings on Thursday
Ottawa Savings Bancorp Scheduled to Post Earnings on Thursday
FIG Partners Comments on First Connecticut Bancorp’s FY2018 Earnings
FIG Partners Comments on First Connecticut Bancorp’s FY2018 Earnings
Brokers Offer Predictions for Ramaco Resources’ FY2018 Earnings
Brokers Offer Predictions for Ramaco Resources’ FY2018 Earnings


© 2006-2018 Ticker Report. Google+.